We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-14.69%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$64.1B
AUM Growth
-$10.3B
Cap. Flow
+$412M
Cap. Flow %
0.64%
Top 10 Hldgs %
13.82%
Holding
4,360
New
217
Increased
1,899
Reduced
1,581
Closed
272

Sector Composition

Rank Sector Weight
1 Technology 13.77%
2 Consumer Discretionary 6.67%
3 Healthcare 6.55%
4 Financials 6.32%
5 Communication Services 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
3476
Tectonic Therapeutic
TECX
$684M
$29.5K ﹤0.01%
2,676
+2,417
+933% +$28.5K
CBAY
3477
DELISTED
Cymabay Therapeutics
CBAY
$29.5K ﹤0.01%
9,987
-9
-0.1% -$21
IGIB icon
3478
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$29.4K ﹤0.01%
575
-3,571
-86% -$186K
CRD.A icon
3479
Crawford & Co Class A
CRD.A
$621M
$29.1K ﹤0.01%
3,732
-5,086
-58% -$39.5K
CASA
3480
DELISTED
Casa Systems, Inc. Common Stock
CASA
$29.1K ﹤0.01%
7,402
-14,943
-67% -$65.1K
CURO
3481
DELISTED
CURO Group Holdings Corp.
CURO
$29.1K ﹤0.01%
5,257
+3,388
+181% +$31K
IVC
3482
DELISTED
Invacare Corporation
IVC
$28.5K ﹤0.01%
22,255
-23,165
-51% -$30.5K
SURF
3483
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$27.6K ﹤0.01%
16,846
+13,727
+440% +$28.5K
JNCE
3484
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$27.6K ﹤0.01%
9,115
+4,623
+103% +$22.5K
SNP
3485
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$27.4K ﹤0.01%
612
+192
+46% +$9.47K
NCMI icon
3486
National CineMedia
NCMI
$248M
$27.1K ﹤0.01%
2,962
-5,502
-65% -$93K
MTEM
3487
DELISTED
Molecular Templates, Inc.
MTEM
$27K ﹤0.01%
1,976
+1,456
+280% +$34.1K
RVP icon
3488
Retractable Technologies
RVP
$20.1M
$27K ﹤0.01%
7,043
+1,301
+23% +$5.32K
OTLK icon
3489
Outlook Therapeutics
OTLK
$160M
$26.4K ﹤0.01%
1,292
+821
+174% +$23.6K
SLNO
3490
DELISTED
Soleno Therapeutics
SLNO
$25.9K ﹤0.01%
9,335
CWBC
3491
Community West Bancshares
CWBC
$706M
$25.5K ﹤0.01%
1,762
+1,504
+583% +$27.6K
HARP
3492
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$24.8K ﹤0.01%
1,299
+1,106
+573% +$28.6K
KB icon
3493
KB Financial Group
KB
$41.7B
$24.8K ﹤0.01%
666
+41
+7% +$1.86K
SPPI
3494
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$24.7K ﹤0.01%
31,652
+16,460
+108% +$14.5K
MBII
3495
DELISTED
Marrone Bio Innovations, Inc.
MBII
$24.4K ﹤0.01%
21,060
+12,127
+136% +$12.7K
CARM
3496
DELISTED
Carisma Therapeutics
CARM
$24.4K ﹤0.01%
1,507
-768
-34% -$8.79K
FSV icon
3497
FirstService
FSV
$6.07B
$24.4K ﹤0.01%
+201
New +$25.3K
VRCA icon
3498
Verrica Pharmaceuticals
VRCA
$84.2M
$24.3K ﹤0.01%
1,268
+1,148
+957% +$57.7K
SBT
3499
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$23.5K ﹤0.01%
4,118
+4,110
+51,375% +$26.9K
NVEC icon
3500
NVE Corp
NVEC
$582M
$23.3K ﹤0.01%
500
+73
+17% +$3.54K

Similar funds

BNP Paribas Financial Markets's Q2 2022 Portfolio in Review

As of Q2 2022, BNP Paribas Financial Markets held 4,360 positions worth $64.1B, down 14% from $74.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BNP Paribas Financial Markets's Q2 2022 filing shows 217 new, 1,899 increased, 1,581 reduced and 272 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M. The largest sale was Invesco QQQ Trust, an estimated $1.87B.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • BNP Paribas Financial Markets's largest Q2 2022 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M.
  • BNP Paribas Financial Markets added most to Microsoft in Q2 2022, an estimated $665M increase.
  • BNP Paribas Financial Markets's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.87B.
  • BNP Paribas Financial Markets fully exited Warner Bros in Q2 2022, selling an estimated $27.5M.
  • BNP Paribas Financial Markets's ten largest holdings make up 14% of its $64.1B portfolio in Q2 2022.
  • BNP Paribas Financial Markets opened 217 new positions and closed 272 in Q2 2022.
  • BNP Paribas Financial Markets's portfolio value fell 14% quarter-over-quarter to $64.1B.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2022, filed 12 Aug 2022.